###begin article-title 0
###xml 85 93 <span type="species:ncbi:9606">patients</span>
###xml 108 125 <span type="species:ncbi:10407">hepatitis B virus</span>
IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C
###end article-title 0
###begin p 1
###xml 303 308 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 333 339 325 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 505 510 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 574 580 566 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 647 653 639 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 665 671 657 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 819 825 811 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 968 969 960 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1036 1042 1028 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1054 1060 1046 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1177 1183 1169 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1373 1378 1365 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1389 1395 1381 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1403 1409 1395 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1512 1517 1504 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1567 1573 1559 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1626 1632 1618 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 104 121 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 123 126 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 450 453 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 472 480 <span type="species:ncbi:9606">patients</span>
###xml 608 616 <span type="species:ncbi:9606">patients</span>
###xml 724 732 <span type="species:ncbi:9606">patients</span>
###xml 767 770 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 883 891 <span type="species:ncbi:9606">patients</span>
###xml 913 916 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1001 1004 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1142 1156 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 1421 1435 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 1717 1731 <span type="species:ncbi:489466">HBV genotype C</span>
Genetic predisposition of nuclear factor-kappa B (NF-kappaB)-signaling pathways linking inflammation to hepatitis B virus (HBV)-induced hepatocellular carcinoma (HCC) remains unresolved. We conducted a case-control study to determine the associations of the polymorphisms within the promoter regions of NFKB1 encoding NF-kappaB1 and NFKBIA encoding IkappaBalpha with the development of HCC. A total of 404 healthy controls, 482 non-HCC subjects with HBV infection and 202 patients with HCC were included. NFKB1 -94ATTG2 allele and GG allele in the 3'-untranslated region of NFKBIA were more prevalent in HCC patients than in the healthy controls. NFKBIA -826CT and NFKBIA -881AG allelic carriages were more prevalent in HCC patients than in the non-HCC subjects with HBV infection. The estimated haplotype frequency of NFKBIA promoter -881G-826T-519C was significantly higher in the patients with HCC than in the HBV-infected subjects without HCC (odds ratio = 3.142, P = 0.002). As compared with the HBV-infected subjects without HCC, NFKBIA -826 T and NFKBIA -881AG allelic carriages were only associated with HCC risk in the subjects with HBV genotype C. The association of NFKBIA -881AG allelic carriage with HCC risk was not affected by liver cirrhosis (LC) status, alanine aminotransferase level and hepatitis B e antigen status. By multivariate regression analysis, NFKB1 -94ATTG2, NFKBIA -826T, NFKBIA -881AG and HBV genotype C were independently associated with an increased risk of HCC. In conclusion, NFKB1 -94ATTG2 allele and haplotype -881G-826T-519C in NFKBIA promoter were associated with hepatocarcinogenesis. NFKBIA -826T and -881AG were associated with the risk of HCC in the subjects infected with HBV genotype C.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 476 477 476 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 640 641 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 642 643 640 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 814 815 812 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 816 817 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 277 294 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 296 299 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 304 321 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 323 326 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 471 474 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 550 553 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 646 660 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 759 762 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 948 951 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third most common cause of cancer mortality. Most HCC cases (>80%) occur in either Eastern Asia or sub-Saharan Africa (1). Major risk factors for the development of HCC are chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), liver cirrhosis (LC), exposure to aflatoxin B1 and diabetes. It has been estimated that 80% of HCC worldwide is etiologically associated with HBV (2). Expression of hepatitis B e antigen (HBeAg) and a high serum level of HBV (i.e. a viral load >/=10 000 copies/ml) are associated with an increased risk of HCC (3,4). HBV genotype C, genotype mixture and viral mutations in the PreS, basal core promoter and enhancer II regions of HBV are also associated with an increased risk of HCC (5-7). HCC is widely accepted to be the outcome of chronic inflammation. However, molecular mechanisms linking chronic inflammation to HBV-induced hepatocarcinogenesis remain largely unresolved.
###end p 3
###begin p 4
###xml 188 189 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 190 191 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 717 719 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 1089 1090 1053 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 1091 1093 1055 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 1094 1096 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 1373 1375 1321 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 1721 1723 1599 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
Activation of nuclear factor-kappa B (NF-kappaB), a hallmark of inflammatory response that is frequently detected in tumors, may constitute a missing link between inflammation and cancer (8,9). NF-kappaB was originally identified as a nuclear factor specific to B cells bound to the B site of the kappa-light chain gene enhancer. NF-kappaB is a heterodimer in Rel family with five members: RelA, RelB, c-Rel, p50/105 (NF-kappaB1) and p52/p100, and the dimeric form of NF-kappaB p50/RelA is the most common form. NF-kappaB has a central role in coordinating the expression of a wide variety of genes that control innate and adaptive immune responses and also has a critical role in cancer development and progression (10). Recent studies have provided a causal link between constitutive activation of NF-kappaB and liver neoplastic progression and have demonstrated that NF-kappaB is essential for promoting inflammation-associated liver cancer and plays important roles in hepatic inflammation, fibrosis and the development of HCC-a process called the 'inflammation-fibrosis-cancer axis' (8,11-13). In normal cells, NF-kappaB is inactivated in the cytoplasm by binding to its inhibitors, IkappaB. When IkappaB proteins are phosphorylated and degraded, NF-kappaB is subsequently released and further translocated into the nucleus, where the gene transcription is initiated (14). The IkappaB family includes IkappaBalpha (IkappaBalpha), IkappaBbeta, IkappaBgamma, IkappaBdelta, IkappaBÏµ, IkappaBzeta, IkappaB-R, Bcl-3, p100 and p105 that are all constitutively expressed except for IkappaBalpha, which is inducibly expressed. IkappaBalpha is a classic form of the IkappaB family that can be found in cytoplasm and nucleus (15).
###end p 4
###begin p 5
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 412 417 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 440 446 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 493 499 481 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 650 652 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 653 655 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 662 668 650 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 670 672 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 741 747 729 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 990 996 978 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1168 1173 1156 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1178 1184 1166 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1282 1287 1270 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1292 1298 1280 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1526 1531 1514 1519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1536 1542 1524 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 146 149 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 309 317 <span type="species:ncbi:9606">patients</span>
###xml 323 326 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1066 1074 <span type="species:ncbi:9606">patients</span>
###xml 1376 1379 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1393 1396 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1562 1565 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Allelic variants in human genome are probably to affect hepatitis B progression after infection and are associated with poor prognosis of chronic HBV infection. Several single-nucleotide polymorphisms (SNPs) or haplotypes have reportedly been associated with an increased or reduced risk of HCC occurrence in patients with HBV infection (16,17). Polymorphic variations in the promoter regions of NF-kappaB1 gene NFKB1 and IkappaBalpha gene NFKBIA and in the 3'-untranslated region (3'-UTR) of NFKBIA were associated with the risks of Hodgkin lymphoma, multiple myeloma, breast cancer, prostate cancer, gastric cancer, colorectal cancer and melanoma (18-24). Kim et al. (25) sequenced six exons and introns including -1000 promoter region of NFKBIA from 16 healthy volunteers and identified 10 polymorphisms. Six of 10 polymorphisms including two SNPs (-673 A>T and -642 C>T) in the promoter region were selected for HCC association study. They could not find any significant association of NFKBIA variants with the development of HCC among chronic hepatitis B (CHB) patients. Except Kim's study, there are no report focusing on the association of the polymorphisms of NFKB1 and NFKBIA and the development of HCC. In this study, we evaluated the associations of the polymorphisms of NFKB1 and NFKBIA with the development of HCC as compared with either healthy controls without HBV infection or HBV-infected subjects without HCC. To our knowledge, it is the first study that clearly demonstrates significant associations of the NFKB1 and NFKBIA polymorphisms with HBV-induced hepatocarcinogenesis.
###end p 5
###begin title 6
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and methods
###end title 6
###begin title 7
Clinical data
###end title 7
###begin p 8
###xml 619 620 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 1137 1139 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 23 26 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 36 44 <span type="species:ncbi:9606">patients</span>
###xml 180 183 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 439 451 <span type="species:ncbi:9606">participants</span>
###xml 505 513 <span type="species:ncbi:9606">patients</span>
###xml 531 539 <span type="species:ncbi:9606">patients</span>
###xml 648 656 <span type="species:ncbi:9606">patients</span>
###xml 672 680 <span type="species:ncbi:9606">patients</span>
###xml 1200 1203 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1620 1631 <span type="species:ncbi:9606">participant</span>
The study involved 404 HBV-infected patients treated at the first and third affiliated hospitals of this university from October 2006 to October 2008, 404 healthy controls without HBV infection from the physical examination center of the First affiliated hospital from January 2007 to October 2008 and 280 asymptomatic hepatitis B surface antigen carriers (ASCs) recruited in an epidemiological survey from September to December 2006. All participants were ethic Chinese. Diagnostic criteria of ASCs, the patients with CHB and the patients with HCC, and exclusion criteria of the subjects were as described previously (6). Only newly diagnosed HCC patients were included; patients with a prior history of HCC or other cancers were excluded. LC was diagnosed by using a Philips iU22 scanner (Philips Medical Systems, Best, The Netherlands) equipped with a 2-4 MHz variable convex probe. The ultrasonography scoring system consisting of liver surface, parenchyma, vascular structure and splenic size was used to describe the existence and severity of cirrhosis. The scores ranged from four for a normal liver to 11 for advanced cirrhosis (26). A score of eight or more was used as the cutoff point for HBV-related ultrasonographic cirrhosis. In addition to ultrasonographic findings, esophageal of gastric varices, low platelet count and cirrhotic complications such as ascites or encephalopathy were used for the diagnosis of clinical cirrhosis. The study protocol conformed to the 1975 Declaration of Helsinki and was approved by the ethics committees of the institutions, and an informed consent was obtained from each participant.
###end p 8
###begin title 9
###xml 15 18 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Examination of HBV serological parameters
###end title 9
###begin p 10
###xml 435 436 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 832 833 811 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 834 836 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 477 480 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 591 594 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 761 764 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Before any treatment, 5 ml fasting blood was split into two blood collection tubes with or without anticoagulant. The serum was separated by centrifugation at 4degreesC and stored in a sterile tube at -80degreesC within 4 h of sample collection. Serological testing for hepatitis B surface antigen, HBeAg, alpha-fetoprotein and liver function examination including alanine aminotransferase (ALT) was performed as described previously (6). Upper limit of normal ALT was 45 U/l. HBV DNA concentration was measured in the LightCyclertrade mark480 (Roche, Basel, Switzerland) using quantitative HBV polymerase chain reaction (PCR) fluorescence diagnostic kits (Fuxun Diagnostics, Shanghai, China). The kit has a certified lower limit of detection of 500 copies/ml. HBV genotype and subgenotype were determined by a multiplex PCR assay (6,27).
###end p 10
###begin title 11
SNP analysis
###end title 11
###begin p 12
###xml 198 203 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 208 215 207 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ins/del</italic>
###xml 236 242 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 269 275 268 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 299 305 298 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 332 338 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 446 450 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB</italic>
###xml 563 565 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 580 586 579 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 694 696 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 711 717 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 827 829 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 844 850 843 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 928 929 927 928 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 1009 1011 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 1363 1367 1354 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB</italic>
###xml 1376 1382 1367 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1406 1412 1391 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1421 1427 1406 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1558 1563 1543 1548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1673 1679 1652 1658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1763 1769 1736 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1862 1868 1829 1835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1945 1951 1906 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 2190 2204 2144 2158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 2227 2232 2181 2186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 2406 2412 2360 2366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 2552 2558 2506 2512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 2695 2701 2649 2655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 2838 2844 2792 2798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
Genomic DNA was extracted from a 200 mul peripheral blood sample using a QIAamp blood kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. Genotyping for the polymorphisms of NFKB1 -94 ins/del ATTG (rs 28720239), NFKBIA 3'-UTR A/G (rs 57898959), NFKBIA -519 C/T (rs 2233408), NFKBIA -826 C/T (rs 2233406) and NFKBIA -881 A/G (rs 3138053) was conducted using PCR-restriction fragment length polymorphism method. Primers for NFKB1 -94 were 5'-TGGGCACAAGTCGTTTATGA-3' and 5'-CTGGAGCCGGTAGGGAAG-3', amplifying a fragment of 281 bps or 285 bps (23). Primers for NFKBIA 3'-UTR were 5'-GGCTGAAAGAACATGGACTTG-3' and 5'-GTACACCATTTACAGGAGGG-3' that amplify a fragment of 424 bps (23). Primers for NFKBIA -519 C/T were 5'-GCTTTCACAACTTCTACCTG-3' and 5'-AGAGTGGAAATGATGGCTG-3', which amplify a fragment of 188 bps (24). Primers for NFKBIA -826 C/T and -881 A/G were 5'-GGTCCTTAAGGTCCAATCG-3' and 5'-GTTGTGGATACCTTGCACTA-3' (underlined, mismatched nucleotide), which amplify a fragment of 200 bps (28). PCR was performed in 25 mul mixture containing 50-100 ng DNA, 1x PCR buffer, 1 U Taq polymerase (TaKaRa Biotechnology, Dalian, China), 0.5 muM each primer (synthesized by Sangon Biotechnology, Shanghai, China) and 0.25 mM deoxynucleoside triphosphate (TaKaRa Biotechnology). The amplification was performed with annealing temperature of 60degreesC (NFKB1 -94 or NFKBIA 3'-UTR) or 55degreesC (NFKBIA -519 or NFKBIA -826 and -881) for 30 s for 35 cycles by using an Autorisierter thermocycler (Eppendorf AG, Humburg, Germany). The PCR product of NFKB1 -94 was digested with Van91 I (New England Biolabs, Ipswitch, MA) at 37degreesC for 18 h. The PCR product of NFKBIA 3'-UTR was digested with HaeIII (TaKaRa) at 37degreesC for 6 h. The PCR product of NFKBIA -519 was digested with MnlI (New England Biolabs) at 37degreesC for 6 h. The PCR product of NFKBIA -826 was digested with XspI (TaKaRa) at 37degreesC for 8 h, whereas that of NFKBIA -881 was digested with TspRI (New England Biolabs) at 65degreesC for 5 h. Both the PCR and restriction products were visualized in 2% agarose gel with 0.2 mug/ml ethidium bromide, together with the DNA ladders, as shown in  (available at Carcinogenesis Online). Genotypes of NFKB1 polymorphisms were distinguished as wild type (WT) (281 bps, ATTG1/ATTG1), heterozygote (ATTG1/ATTG2) and polymorphic homozygote (45 and 240 bps, ATTG2/ATTG2). Genotypes of NFKBIA 3'-UTR polymorphisms were determined as WT (424 bps, AA), heterozygote (AG) and polymorphic homozygote (108 and 316 bps, GG). Genotypes of NFKBIA -519 polymorphisms were determined as WT (188 bps, CC), heterozygote (CT) and polymorphic homozygote (121 and 67 bps, TT). Genotypes of NFKBIA -826 polymorphisms were determined as WT (200 bps, CC), heterozygote (CT) and polymorphic homozygote (180 and 20 bps, TT). Genotypes of NFKBIA -881 polymorphisms were determined as WT (200 bps, AA), heterozygote (200, 129 and 71 bps, AG).
###end p 12
###begin title 13
Statistical analysis
###end title 13
###begin p 14
###xml 335 336 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 537 538 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 656 657 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 657 662 655 660 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">entry</sub>
###xml 671 672 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 672 679 670 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">removal</sub>
###xml 920 921 918 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 302 305 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The frequencies of all SNPs in health controls were tested for conformation to Hardy-Weinberg equilibrium online (). Statistical analyses were performed using the Statistical Program for Social Sciences (SPSS15.0 for Windows, SPSS, Chicago, IL). Categorical variables, like the frequencies of SNPs and HBV genotypes, were tested by chi2 test. Continuous variables, like serum viral load and ALT level with skewed distribution, were adjusted to normal distribution by transformation into logarithmic function and then tested by Student's t-test. To determine the factors contributing independently to HCC, forward stepwise multivariate regression analysis (Pentry = 0.05, Premoval = 0.10) was performed to obtain the adjusted odds ratios (AOR) of polymorphisms for HCC risk and their 95% confidence intervals (CI). The estimated haplotype frequencies were determined by the estimating haplotype-frequencies program (). A P value of <0.05 was considered as statistically significant. All statistical tests were two sided.
###end p 14
###begin title 15
Results
###end title 15
###begin p 16
###xml 57 64 57 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 27 39 <span type="species:ncbi:9606">participants</span>
###xml 91 94 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
###xml 280 283 <span type="species:ncbi:9606">men</span>
###xml 295 309 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 347 355 <span type="species:ncbi:9606">patients</span>
###xml 377 380 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 390 402 <span type="species:ncbi:9606">participants</span>
###xml 448 451 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 484 487 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 497 509 <span type="species:ncbi:9606">participants</span>
###xml 534 542 <span type="species:ncbi:9606">patients</span>
The characteristics of the participants are presented in Table I. Healthy controls without HBV infection, the patients with LC and those with CHB were age and sex matched to the patients with HCC. The patients with HCC were significantly older and there were higher proportion of men than ASCs. HBV genotype C (C2, 95.5%) was more frequent in the patients with HCC than in the HBV-infected participants without HCC (P < 0.001). Serum viral load of HBV was significantly higher in the HBV-infected participants without HCC than in the patients with HCC, and the same were true for the frequencies of HBeAg seropositivities and ALT levels.
###end p 16
###begin p 17
Characteristics of study subjects and their association with HCC
###end p 17
###begin p 18
###xml 14 15 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 41 44 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Data shown as N (%), except age, ALT and HBV DNA; ND, no data.
###end p 18
###begin p 19
Between ASC and HCC.
###end p 19
###begin p 20
Between ASC and HCC.
###end p 20
###begin p 21
Between HCC and CHB and between HCC and LC.
###end p 21
###begin p 22
Between CHB and HCC.
###end p 22
###begin p 23
Between HCC and ASC and between HCC and LC.
###end p 23
###begin p 24
Between CHB and HCC.
###end p 24
###begin p 25
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 198 204 198 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 303 311 303 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table II</xref>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 517 518 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 555 561 555 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 626 627 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 661 667 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 804 805 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 881 887 881 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 952 953 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 967 973 967 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1038 1039 1038 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1084 1089 1084 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1249 1250 1249 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1261 1269 1261 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table II</xref>
###xml 1446 1451 1446 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1465 1471 1465 1471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1549 1554 1549 1554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1565 1571 1565 1571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1583 1589 1583 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
###xml 240 243 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 418 426 <span type="species:ncbi:9606">patients</span>
###xml 448 456 <span type="species:ncbi:9606">patients</span>
###xml 1345 1348 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1358 1366 <span type="species:ncbi:9606">patients</span>
###xml 1517 1520 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1530 1538 <span type="species:ncbi:9606">patients</span>
###xml 1642 1645 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1655 1663 <span type="species:ncbi:9606">patients</span>
###xml 1685 1688 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Genotype data of all loci in the healthy controls were conformed to Hardy-Weinberg equilibrium (P > 0.05 for each). Genotype data of NFKB1 -94, NFKBIA 3'-UTR and NFKBIA -826, except NFKBIA -519 and NFKBIA -881, in the non-HCC patients with HBV infection did not conformed to Hardy-Weinberg equilibrium (Table II). After being adjusted with age and sex, NFKB1 -94 ATTG2/ATTG2 allelic carriage was more prevalent in the patients with HCC than in the patients with CHB (41.1 versus 28.2%, AOR = 2.17, 95% CI: 1.26-3.75, P = 0.006), and the same was true for NFKBIA -881AG allele (18.8 versus 6.9%, AOR = 3.288, 95%CI: 1.71-6.33, P < 0.001). As compared with ASCs, NFKBIA 3'-UTR GG allelic carriage was significantly associated with an increased risk of HCC (32.2 versus 13.6%, AOR = 2.44, 95%CI: 1.36-4.36, P = 0.003) after the adjustment with age and sex, and the same were true for NFKBIA -826T (CT+TT) (26.2 versus 15.7%, AOR = 2.19, 95%CI: 1.29-3.71, P = 0.003) and NFKBIA -881AG alleles (18.8 versus 6.8%, AOR = 3.20, 95%CI: 1.63-6.28, P = 0.001). Interestingly, we also found that NFKB1 -94ATTG2 allelic carriage (ATTG1/ATTG2+ ATTG2/ATTG2) was more prevalent in ASCs than in the healthy controls (77.9 versus 69.3%, OR = 1.670, 95%CI: 1.10-2.52, P = 0.016). Table II shows the frequencies of all polymorphisms in the healthy controls and the HBV-infected patients with and without HCC. As compared with the age-, sex-matched healthy controls, NFKB1 -94ATTG2 and NFKBIA 3'-UTR GG alleles were more prevalent in the HBV-infected patients with HCC. NFKB1 -94ATTG2, NFKBIA -826CT and NFKBIA -881AG allelic carriages were more prevalent in the HBV-infected patients with HCC than in the HBV-infected subjects without HCC.
###end p 25
###begin p 26
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 95 107 <span type="species:ncbi:9606">participants</span>
The frequencies of the polymorphisms at NFKB1 -94 and NFKBIA 3'-UTR, -519, -826 or -881 in the participants
###end p 26
###begin p 27
###xml 80 83 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 122 125 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 152 155 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
AOR, odds ratio adjusted by age and sex; AOR1: healthy controls versus HCC with HBV infection; OR2 and AOR2: non-HCC with HBV infection versus HCC with HBV infection; HWE, Hardy-Weinberg equilibrium; ND, no data.
###end p 27
###begin p 28
###xml 23 24 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Data were presented as n (%).
###end p 28
###begin p 29
Significance probability determined by HWE test.
###end p 29
###begin p 30
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 101 107 101 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 484 490 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 501 507 501 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 677 683 675 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 877 891 875 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 4 7 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 78 83 <span type="species:ncbi:9606">women</span>
###xml 222 225 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 260 263 <span type="species:ncbi:9606">men</span>
###xml 377 380 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 451 454 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 464 472 <span type="species:ncbi:9606">patients</span>
###xml 606 609 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 789 792 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The HBV-infected subjects were stratified into sex- or age-matched groups. In women, NFKB1 -94ATTG2, NFKBIA -826T and NFKBIA -881G allelic carriages were significantly associated with the risk of HCC, as compared with the HBV-infected subjects without HCC. In men, NFKBIA -881AG allelic carriage was significantly associated with an increased risk of HCC, as compared with the HBV-infected subjects without HCC. In those <53 years (average age of the HBV-infected patients with HCC), NFKBIA -826T and NFKBIA -881AG allelic carriages were significantly associated with the risk of HCC, as compared with the HBV-infected subjects without HCC. In those at the age of >/=53 years, NFKBIA -881AG allelic carriage was significantly associated with an increased risk of HCC, as compared with the HBV-infected subjects without HCC. The results are presented in the  and  (available at Carcinogenesis Online), respectively.
###end p 30
###begin p 31
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 503 504 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 785 791 783 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 928 933 926 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 944 950 942 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 962 968 960 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1096 1110 1094 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 18 21 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
###xml 200 203 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
###xml 244 247 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 538 541 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 712 720 <span type="species:ncbi:9606">patients</span>
###xml 726 729 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 756 764 <span type="species:ncbi:9606">patients</span>
###xml 770 773 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
We stratified the HBV-infected subjects into HBeAg-positive and HBeAg-negative groups and then evaluated the association of the polymorphisms with the development of HCC between the HCC patients with HBV infection and the non-HCC patients with HBV infection. NFKBIA -881AG allelic carriage was associated with an increased risk of HCC, either in HBeAg-positive group (22.9 versus 8.1%, OR = 3.36, 95% CI: 1.46-7.75, P = 0.003) or in HBeAg-negative group (17.5 versus 5.9%, OR = 3.42, 95% CI: 1.78-6.57, P = 0.000). We then stratified the HBV-infected subjects into normal ALT (<45 U/l) and abnormal (>/=45U/l) groups and evaluated the association of the polymorphisms with the development of HCC between the HCC patients with HBV infection and the non-HCC patients with HBV infection. NFKBIA -881AG allelic carriage was significantly associated with an increased risk of HCC either in normal ALT group or in abnormal ALT group. NFKB1 -94ATTG2, NFKBIA 3'-UTR and NFKBIA -826T allelic carriages were significantly associated with the risk of HCC in normal ALT group, as shown in the  (available at Carcinogenesis Online).
###end p 31
###begin p 32
###xml 136 142 136 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 153 159 153 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 347 356 347 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table III</xref>
###xml 18 21 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 45 59 <span type="species:ncbi:489460">HBV genotype B</span>
###xml 65 79 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 264 278 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 301 315 <span type="species:ncbi:489466">HBV genotype C</span>
We stratified the HBV-infected subjects into HBV genotype B- and HBV genotype C-infected groups. After the adjustment with age and sex, NFKBIA -826T and NFKBIA -881AG allelic carriages were significantly associated with the risk of HCC in the groups infected with HBV genotype C, as compared with the HBV genotype C-infected subjects without HCC (Table III).
###end p 32
###begin p 33
###xml 74 77 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Association of the polymorphisms with the development of HCC in different HBV genotype groups
###end p 33
###begin p 34
AOR, odd ratio adjusted by age and sex; ND, no data.
###end p 34
###begin p 35
###xml 23 24 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Data were presented as n (%).
###end p 35
###begin p 36
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
P = 0.024.
###end p 36
###begin p 37
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
P = 0.000.
###end p 37
###begin p 38
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 185 193 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl4">Table IV</xref>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 150 153 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
We also found that the estimated haplotype frequency of NFKBIA promoter -881G-826T-519C was significantly higher in the patients with HCC than in the HBV-infected subjects without HCC (Table IV).
###end p 38
###begin p 39
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 76 79 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 115 118 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The estimated haplotype frequencies of NFKBIA promoter polymorphisms in the HBV-infected patients with HCC and the HBV-infected subjects without HCC
###end p 39
###begin p 40
###xml 7 8 7 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
OR and P value were not calculated due to small size of case number.
###end p 40
###begin p 41
###xml 240 246 240 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 363 371 363 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 478 484 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 541 542 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 556 561 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 629 630 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 193 201 <span type="species:ncbi:9606">patients</span>
###xml 293 301 <span type="species:ncbi:9606">patients</span>
###xml 403 411 <span type="species:ncbi:9606">patients</span>
###xml 429 437 <span type="species:ncbi:9606">patients</span>
There were no significant differences in the frequencies of the polymorphisms in all loci between the non-HCC patients with and without LC, and the same was true for the difference between HCC patients with and without LC. The frequency of NFKBIA -881AG allele was significantly higher in the patients with HCC than in those without HCC, regardless of LC status (Figure 1). As compared with the non-HCC patients with LC, the HCC patients had significantly higher frequencies of NFKBIA -881AG (18.8 versus 6.5%, OR = 3.32, 95% CI: 1.35-8.17, P = 0.006) and NFKB1 -94ATTG2 alleles (82.7 versus 71.7%, OR = 1.88, 95% CI: 1.05-3.36, P = 0.032).
###end p 41
###begin p 42
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
###xml 108 111 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
NFKBIA -881AG allelic carriage was significantly associated with HCC as compared with non-HCC patients with HBV infection, regardless of LC state.
###end p 42
###begin p 43
###xml 113 120 113 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl5">Table V</xref>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 383 389 383 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 523 529 523 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 686 691 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 722 728 722 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 915 929 915 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 299 313 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 548 562 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 630 638 <span type="species:ncbi:9606">patients</span>
###xml 849 857 <span type="species:ncbi:9606">patients</span>
Independent factors contributing to HCC were evaluated in the forward stepwise multivariate regression analysis (Table V). NFKB1 -94ATTG2 allelic carriage was independently associated with an increased risk of HCC, as compared with the healthy controls. Age, male, NFKBIA -816T allelic carriage and HBV genotype C were independently associated with an increased risk of HCC, whereas NFKBIA -519T allelic carriage was inversely associated with an increased risk of HCC, if ASCs were used as controls. NFKB1 -94ATTG2 allele, NFKBIA -881AG allele and HBV genotype C were independently associated with an increased risk of HCC if the patients with CHB and those with LC served as controls. NFKB1 -94ATTG2 allelic carriage and NFKBIA -881AG allelic carriage and genotype C were independently associated with increased risks of HCC if combining ASCs, the patients with CHB and those with LC as controls ( is available at Carcinogenesis Online).
###end p 43
###begin p 44
Multivariate regression analysis for factors independently associated with the risk of HCC
###end p 44
###begin p 45
ND, no data; NS, no statistical significance.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 205 213 205 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table II</xref>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 531 539 531 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table II</xref>
###xml 558 563 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 764 771 764 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl5">Table V</xref>
###xml 774 779 774 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 976 990 976 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 1049 1054 1049 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1205 1210 1205 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1236 1241 1236 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1282 1287 1282 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1477 1479 1477 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 1565 1570 1565 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 1645 1650 1641 1646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
###xml 467 470 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 480 488 <span type="species:ncbi:9606">patients</span>
###xml 644 647 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 910 918 <span type="species:ncbi:9606">patients</span>
###xml 1104 1107 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1129 1132 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1793 1796 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
This study firstly demonstrated that the ATTG2 (ATTG1/ATTG2 + ATTG2/ATTG2) allelic carriage at -94 site of NFKB1 promoter significantly increased the risk of HCC either compared with the healthy controls (Table II) or compared with the patients with CHB after being adjusted with age and sex. This study also revealed that NFKB1 -94ATTG2 allelic carriage was more prevalent in ASCs than in the healthy controls (OR = 1.67; 95% CI: 1.10-2.52) and more frequent in the HBV-infected patients without HCC than in the healthy controls (Table II), indicating that NFKB1 -94ATTG2 allelic carriage might also contribute to the risk of becoming chronic HBV infection. AOR of the ATTG2 allele for HCC was higher in HCC versus the healthy controls than in HCC versus CHB+LC (Table V). NFKB1 -94ATTG2 allelic carriage was independently associated with an increased risk of HCC in the multivariate analysis using ASCs, the patients with CHB and those with LC as controls ( is available at Carcinogenesis Online). Based on these observations, we hypothesize that NFKB1 -94ATTG2 allelic carriage might play a role from HBV chronic infection to HBV-induced hepatocarcinogenesis. Insertion/deletion of ATTG at -94 site of NFKB1 promoter is a functional NFKB1 polymorphism. The ATTG insertion at the NFKB1 promoter significantly increased the promoter activity, as demonstrated by the promoter-luciferase reporter assay in transient transfection and differential nuclear protein binding assays (29), indicating that the individuals with the ATTG2 allele usually had higher levels of NFKB1 transcript and further increase in production of NF-kappaB protein. Thus, NFKB1 -94ATTG2 allelic carriage-associated upregulation of NF-kappaB1 might play a role from chronic inflammation to hepatocarcinogenesis caused by HBV chronic infection.
###end p 47
###begin p 48
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 436 441 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFkB1</italic>
###xml 446 452 446 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFkBIA</italic>
###xml 481 495 481 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 625 627 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 655 661 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 861 867 857 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1188 1190 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 1400 1402 1380 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 1405 1411 1385 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1516 1522 1488 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1714 1716 1682 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 1781 1787 1749 1755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1799 1805 1767 1773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 1903 1912 1871 1880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table III</xref>
###xml 2148 2150 2112 2114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 2336 2337 2300 2301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 2517 2519 2461 2463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
###xml 2647 2649 2591 2593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 2878 2884 2818 2824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 2895 2901 2835 2841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 3070 3076 3002 3008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 3148 3154 3080 3086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 3165 3171 3097 3103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 3343 3350 3275 3282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl5">Table V</xref>
###xml 3446 3452 3378 3384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 3562 3570 3494 3502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl4">Table IV</xref>
###xml 3594 3600 3526 3532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 765 779 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 1007 1015 <span type="species:ncbi:9606">patients</span>
###xml 1864 1872 <span type="species:ncbi:9606">patients</span>
###xml 1887 1901 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 1943 1946 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 2056 2059 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 2261 2275 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 2302 2305 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 2340 2343 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 2575 2589 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 2662 2665 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 3278 3281 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 3510 3518 <span type="species:ncbi:9606">patients</span>
###xml 3846 3849 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
In this study, NFKBIA promoter polymorphisms were selected based on their frequency determined in a preliminary screening of 200 normal subjects. The polymorphism at position -881 was further selected based on potential functional effects due to their location within transcription factor binding sites (). From this website and literature (30), we created schematic diagrams to show several known transcription factor binding sites in NFkB1 and NFkBIA promoters ( is available at Carcinogenesis Online). The -881 locus is within a consensus binding site (TAAA/TNTAGGTCA) for the retinoic acid-related orphan receptor alpha (30). This study revealed that NFKBIA -881G allelic carriage was an independent risk factor of HCC, especially in the subjects infected with HBV genotype C. Although there is not direct evidence showing that the -881G at the promoter of NFKBIA decreases the promoter activity, indirect evidences indicate this possibility. For instance, NF-kappaB expression was twice as high in the patients with sarcoidosis compared with the control subjects, whereas the -881G allelic carriage and -826T allelic carriage were more prevalent in sarcoidosis than in the controls (31), indicating that the -881G and -826T allelic carriages might be associated with an increased activity of NF-kappaB. Since IkBalpha is an absolute requirement for normal termination of the NF-kappaB response (15), NFKBIA -881G and -826T allelic carriages are therefore speculated to retard efficient IkappaBalpha expression. NFKBIA -881G might alter the binding ability of retinoic acid-related orphan receptor alpha, a group of transcriptional factors with potential roles in osteoporosis, autoimmune diseases and cancer (30), and contribute to hepatocarcinogenesis. This study found that NFKBIA -881 G and NFKBIA -826 T allelic carriages were only associated with HCC in patients infected with HBV genotype C (Table III). We speculate that the large HBV surface protein and the X protein of genotype C might involve in this process. The PreS2 domain of the large HBV surface protein is able to activate a variety of promoter elements including NF-kappaB (32), whereas our recent meta-analysis have shown that viral mutations in PreS region are significantly higher in HBV genotype C than in genotype B during HBV-induced hepatocarcinogenesis (7). HBV X protein is able to activate NF-kappaB by directly interacting with IkappaBalpha at amino acids 249-253 of IkappaBalpha in the C-terminal part of the sixth ankyrin repeat (33), while nucleotide change of codon 38 in the X gene of HBV genotype C is independently associated with the development of HCC (34). The large HBV surface protein and the X protein of genotype C might specifically activate important transcriptional factors in NF-kappaB-signaling pathways. Moreover, genotype C products, e.g. X protein, might be able to bind NFKBIA -881G and NFKBIA -826T alleles specifically and affect IkappaBalpha expression. These speculations remain to be investigated in future. In this study, multivariate analysis showed that NFKBIA -519T allelic carriage was inversely associated with HCC risk, whereas NFKBIA -881G and NFKBIA -826T allelic carriages were independently associated with an increased risk of HCC, as compared with the HBV-infected non-HCC subjects with or without clinical symptoms (Table V). These results were consistent with the observation that the estimated haplotype frequency of NFKBIA promoter -881G-826T-519C was significantly higher in the patients with HCC than in the subjects without HCC (Table IV). The polymorphisms in NFKBIA promoter may also affect the binding of other unknown transcription factors. Alteration of one or more of these transcription factor binding sites could reduce the levels of IkappaBalpha expression, increase NK-kappaB activity and contribute to HBV-induced hepatocarcinogenesis.
###end p 48
###begin p 49
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 411 413 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 126 134 <span type="species:ncbi:9606">patients</span>
###xml 444 447 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
This study also showed that no significant differences in the frequencies of polymorphisms in all loci were found between the patients with and without LC and NFKBIA -881G allelic carriage was associated with an increased risk of HCC regardless of LC status, indicating that the polymorphisms were not associated with cirrhosis. Since NF-kappaB plays important roles in the 'inflammation-fibrosis-cancer axis' (13), the role of IkappaBalpha on HBV-induced hepatocarcinogenesis may be not limited to NK-kappaB regulation.
###end p 49
###begin p 50
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 657 658 657 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 0 14 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 49 52 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 415 418 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 623 626 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 782 790 <span type="species:ncbi:9606">patients</span>
###xml 880 883 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 893 901 <span type="species:ncbi:9606">patients</span>
###xml 1183 1186 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
HBV genotype C, elevated ALT, high viral load of HBV and HBeAg positivity have been demonstrated to increase the risk of HCC (4,5,35). In this study, however, elevated ALT, viral load and HBeAg were inversely associated with the development of HCC, even in age-, gender-matched groups. This difference is possibly due to different study design and different study population recruited. In prospective studies, ALT, HBV viral load and HBeAg have been proved to be risk factors for HCC because these data are usually collected at the beginning of cohort establishment. Because viral load and HBeAg change dramatically during HBV-induced hepatocarcinogenesis (6), it is difficult to draw the same conclusion in prevalence case-control study (36). This study recruited the hospitalized patients with CHB and those with LC whose clinical symptoms and/or syndromes were usually severe. HBV-infected patients with severe symptoms usually accompany with high ALT level and high viral load. Nevertheless, the associations of the polymorphisms on the development of HCC should be reliable in this case-control study because the polymorphisms are germ line transmitted and do not change during HBV-induced hepatocarcinogenesis.
###end p 50
###begin p 51
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 286 292 286 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 357 363 357 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 374 380 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKBIA</italic>
###xml 83 97 <span type="species:ncbi:489466">HBV genotype C</span>
###xml 323 326 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 472 486 <span type="species:ncbi:489466">HBV genotype C</span>
In conclusion, NFKB1 -94ATTG2, NFKBIA -826T and NFKBIA -881G allelic carriages and HBV genotype C were independently associated with an increased risk of HCC, whereas NFKBIA -519T allelic carriage was inversely associated with an increased risk of HCC. The haplotype -881G-826T-519C in NFKBIA promoter were associated with HBV-induced hepatocarcinogenesis. NFKBIA -826T and NFKBIA -881G allelic carriages were associated with the risk of HCC in the subjects infected with HBV genotype C.
###end p 51
###begin title 52
Supplementary material
###end title 52
###begin p 53
- and  and  can be found at
###end p 53
###begin title 54
Funding
###end title 54
###begin p 55
###xml 0 50 0 50 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ministry of Health, the People's Republic of China</funding-source>
###xml 52 66 52 66 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2008ZX10002-15</award-id>
###xml 77 118 77 118 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shanghai Science and Technology Committee</funding-source>
###xml 120 129 120 129 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">08XD14001</award-id>
###xml 140 164 140 164 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shanghai Board of Health</funding-source>
###xml 166 173 166 173 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">08GWD02</award-id>
###xml 175 185 175 185 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">08GWZX0201</award-id>
###xml 187 197 187 197 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">08GWZX0101</award-id>
###xml 24 30 <span type="species:ncbi:9606">People</span>
Ministry of Health, the People's Republic of China (2008ZX10002-15 to G.C.); Shanghai Science and Technology Committee (08XD14001 to G.C.); Shanghai Board of Health (08GWD02, 08GWZX0201, 08GWZX0101 to G.C.).
###end p 55
###begin title 56
Supplementary Material
###end title 56
###begin title 57
[Supplementary Data]
###end title 57
###begin title 58
Abbreviations
###end title 58
###begin p 59
alanine aminotransferase
###end p 59
###begin p 60
adjusted odds ratios
###end p 60
###begin p 61
asymptomatic hepatitis B surface antigen carriers
###end p 61
###begin p 62
chronic hepatitis B
###end p 62
###begin p 63
confidence intervals
###end p 63
###begin p 64
hepatitis B e antigen
###end p 64
###begin p 65
###xml 0 17 <span type="species:ncbi:10407">Hepatitis B virus</span>
Hepatitis B virus
###end p 65
###begin p 66
hepatocellular carcinoma
###end p 66
###begin p 67
IkappaBalpha
###end p 67
###begin p 68
liver cirrhosis
###end p 68
###begin p 69
nuclear factor-kappa B
###end p 69
###begin p 70
polymerase chain reaction
###end p 70
###begin p 71
single-nucleotide polymorphism
###end p 71
###begin p 72
3'-untranslated region
###end p 72
###begin p 73
wild type
###end p 73
###begin p 74
The authors thank Ms Liping Lin and Mr Xingxing Xu (Department of Epidemiology, Second Military Medical University, Shanghai, China) for their technical assistance and Dr. Yaoliang Pan (Physical Examination Center, the First Affiliated Hospital, Second Military Medical University, Shanghai, China) for his help in recruiting healthy controls.
###end p 74
###begin p 75
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest Statement:</italic>
Conflict of Interest Statement: None declared.
###end p 75
###begin article-title 76
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
###end article-title 76
###begin article-title 77
Epidemiology of hepatocellular carcinoma
###end article-title 77
###begin article-title 78
###xml 71 88 <span type="species:ncbi:10407">hepatitis B virus</span>
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
###end article-title 78
###begin article-title 79
Hepatitis B e antigen and the risk of hepatocellular carcinoma
###end article-title 79
###begin article-title 80
###xml 0 17 <span type="species:ncbi:10407">Hepatitis B virus</span>
###xml 94 97 <span type="species:ncbi:9606">men</span>
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men
###end article-title 80
###begin article-title 81
###xml 8 25 <span type="species:ncbi:10407">hepatitis B virus</span>
Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area
###end article-title 81
###begin article-title 82
###xml 21 38 <span type="species:ncbi:10407">hepatitis B virus</span>
Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis
###end article-title 82
###begin article-title 83
NF-kappaB functions as a tumour promoter in inflammation-associated cancer
###end article-title 83
###begin article-title 84
###xml 59 82 <span type="species:ncbi:333760">human papillomavirus 16</span>
Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein
###end article-title 84
###begin article-title 85
Nuclear factor-kappaB in cancer development and progression
###end article-title 85
###begin article-title 86
Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma
###end article-title 86
###begin article-title 87
Inflammation and liver cancer: new molecular links
###end article-title 87
###begin article-title 88
Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis
###end article-title 88
###begin article-title 89
The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer
###end article-title 89
###begin article-title 90
I kappa B proteins: structure, function and regulation
###end article-title 90
###begin article-title 91
###xml 76 84 <span type="species:ncbi:9606">patients</span>
###xml 98 115 <span type="species:ncbi:10407">hepatitis B virus</span>
Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection
###end article-title 91
###begin article-title 92
###xml 94 102 <span type="species:ncbi:9606">patients</span>
###xml 116 133 <span type="species:ncbi:10407">hepatitis B virus</span>
MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
###end article-title 92
###begin article-title 93
Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma
###end article-title 93
###begin article-title 94
Haplotypic structure across the I kappa B alpha gene (NFKBIA) and association with multiple myeloma
###end article-title 94
###begin article-title 95
Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer
###end article-title 95
###begin article-title 96
A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer
###end article-title 96
###begin article-title 97
###xml 104 112 <span type="species:ncbi:9606">patients</span>
Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients
###end article-title 97
###begin article-title 98
###xml 158 166 <span type="species:ncbi:9606">patients</span>
Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients
###end article-title 98
###begin article-title 99
Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations
###end article-title 99
###begin article-title 100
###xml 111 114 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 115 123 <span type="species:ncbi:9606">patients</span>
Identification of variants in NFKBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patients
###end article-title 100
###begin article-title 101
Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis
###end article-title 101
###begin article-title 102
###xml 35 52 <span type="species:ncbi:10407">hepatitis B virus</span>
Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypes B1, B2, C1 and C2
###end article-title 102
###begin article-title 103
###xml 39 47 <span type="species:ncbi:9606">patients</span>
IkappaBalpha promoter polymorphisms in patients with primary Sjogren's syndrome
###end article-title 103
###begin article-title 104
Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis
###end article-title 104
###begin article-title 105
Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism
###end article-title 105
###begin article-title 106
Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis
###end article-title 106
###begin article-title 107
###xml 4 21 <span type="species:ncbi:10407">hepatitis B virus</span>
The hepatitis B virus large surface protein (LHBs) is a transcriptional activator
###end article-title 107
###begin article-title 108
###xml 45 62 <span type="species:ncbi:10407">hepatitis B virus</span>
Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha
###end article-title 108
###begin article-title 109
###xml 47 64 <span type="species:ncbi:10407">hepatitis B virus</span>
Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma
###end article-title 109
###begin article-title 110
###xml 108 111 <span type="species:ncbi:9606">men</span>
Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men
###end article-title 110
###begin article-title 111
###xml 8 25 <span type="species:ncbi:10407">hepatitis B virus</span>
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study
###end article-title 111

